Automatic implantable cardioverter defibrillator (AICD) was commercially available for use in patients with malignant ventricular tachycardia and ventricular fibrillation since its meeting with FDA approval in 1985.

• 摘要植入式心脏去颤器在1985年由美国FDA核准上市，用来治疗在心室频脉及心室震颤的病人身上有良好的功效。